Di Luca A, Del Rio A, Bosco M, Di Luca N M
Institute of Public Health, Section of Legal Medicine, School of Medicine, Catholic University, Rome.
Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy.
Clin Ter. 2018 Mar-Apr;169(2):e77-e81. doi: 10.7417/T.2018.2058.
The paper's authors aim to elaborate on law 22 dicembre 2017, n. 219 , designed to regulate informed consent practices and advance health care directives", which has sparked a passionate debate centered on the substantial innovation achieved over the past decades in bio-medical science and at the same time, the noteworthy accomplishments made in enforcing human and personal rights. Within the paper, article three is delved into, which covers the creation of the so-called DAT ("Disposizioni anticipate di trattamento", advance health care directives), by which patients, in light of possible future incapacity to choose, can express their convictions and decisions on how to be treated and their consent or dissent to undergo treatments and procedures, including artificial nutrition and hydration. The authors peruse the new law's provisions through a medical perspective, and observe how they are heavily tilted towards patient choice, thus making doctors little more than mere tools of such decisions.
该论文的作者旨在详细阐述2017年12月22日第219号法律,该法律旨在规范知情同意做法并推进医疗保健指令,这引发了一场激烈的辩论,其焦点在于过去几十年生物医学科学取得的重大创新,以及同时在加强人权和个人权利方面取得的显著成就。在论文中,对第三条进行了深入探讨,该条涉及所谓的DAT(“预先治疗安排”,即医疗保健指令)的创建,通过这一指令,患者鉴于未来可能无法做出选择的情况,可以表达他们对如何接受治疗的信念和决定,以及他们对接受治疗和程序(包括人工营养和补水)的同意或不同意。作者从医学角度研读了新法律的条款,并观察到这些条款严重倾向于患者的选择,从而使医生仅仅成为这些决定的执行者。